Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Vor Biopharma ( (VOR) ).
Vor Biopharma Inc. has welcomed Han Choi, M.D., LL.M., to their executive team as the new Chief Financial Officer effective September 30, 2024. Dr. Choi’s extensive background, including over twenty years at Oracle Investment Management and experience in healthcare investments, positions him as a significant asset to Vor Bio’s financial and strategic operations. His appointment is bolstered by an attractive compensation package, including a substantial base salary, performance-based bonuses, and an inducement stock option grant, all aimed at steering the company forward in the cell and genome engineering industry.
See more insights into VOR stock on TipRanks’ Stock Analysis page.
